OXFORD ASSET MANAGEMENT LLP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$409,000
-73.0%
3,918
-46.2%
0.01%
-62.1%
Q2 2018$1,514,000
-3.3%
7,281
-23.2%
0.03%
-12.1%
Q1 2018$1,565,000
-25.0%
9,478
-37.6%
0.03%
-26.7%
Q4 2017$2,086,000
+37.6%
15,178
+34.9%
0.04%
+55.2%
Q3 2017$1,516,000
-11.6%
11,252
-20.3%
0.03%
-14.7%
Q2 2017$1,714,000
-55.9%
14,115
-61.1%
0.03%
-69.4%
Q1 2016$3,890,000
+29.6%
36,329
+29.9%
0.11%
+56.3%
Q4 2015$3,001,000
-12.6%
27,975
-37.2%
0.07%
-18.4%
Q1 2015$3,435,000
-71.6%
44,553
-80.4%
0.09%
-67.3%
Q4 2014$12,076,000
+15.2%
226,994
+1.3%
0.27%
+11.3%
Q3 2014$10,483,000
+18.5%
224,181
+56.5%
0.24%
-16.7%
Q2 2014$8,849,000
-7.4%
143,233
+0.9%
0.29%
+3.2%
Q1 2014$9,551,000
+51.0%
142,000
+18.1%
0.28%
+74.8%
Q4 2013$6,326,000
+89.1%
120,274
+34.5%
0.16%
+74.7%
Q2 2013$3,345,00089,4000.09%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders